• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Express Scripts

Express Scripts

Express Scripts Holding Co ESRX 4 Star

Last Price$90.44Day Change (%)0.27%
Open Price$90.07Day Change ($)0.24
Day Range90.01–91.2152-Week Range65.08–91.21

As of Fri 5/22/2015 5:00:00 PM | USD

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  1. Friday Five: Fed Takes the Market's Hand

    The fact that the Fed minutes were a non-event this week is a good sign for its communication policy. Plus, Wal-Mart shares a good buy for the patient, and more.

  2. For CVS, Big Bet On Pricey Medicines

    For CVS, Big Bet On Pricey Medicines

  3. Express Scripts Research Highlights $52 Billion Challenge for U.S. Healthcare System

    Express Scripts Research Highlights $52 Billion Challenge for U.S. Healthcare System

  4. SaveRxAccess Raises Concerns on Department of Defense Cuts for Essential Medications for Thousands of Military Members

    SaveRxAccess Raises Concerns on Department of Defense Cuts for Essential Medications for Thousands of Military Members

  5. Express Scripts Announces Accelerated Share Repurchase Transaction

    Express Scripts Announces Accelerated Share Repurchase Transaction

  6. Express Scripts : One of the Widest Moats in Health Care

    Investors can pick up shares of this pharmacy benefit manager, which enjoys enormous supplier-pricing and scale advantages, at a significant discount.

  7. Vertex's Cystic-Fibrosis Drug Faces Big Test

    Vertex's Cystic-Fibrosis Drug Faces Big Test

  8. Morningstar Minute: 3 Pillars to Express Scripts' Wide Moat

    Pharmacy benefits manager Express Scripts is attractively priced given its ability to fend off competitors for years to come.

  9. Express Scripts Well Positioned for New Health-Care Order

    The wide-moat pharmacy benefit manager is still undervalued.

  10. PBMs: Health Care's Hidden Gems

    Pharmacy benefit managers aren't household names, but recent consolidation in the industry is proving out the power of scale for these firms, says Morningstar's Matt Coffina.

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.